Publications by authors named "Houppe C"

Claim this Profile
C
Corrigendum to "The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy" [Eur. J. Pharmacol. 991 (2025) 177310].
F Raineri, L Larue, C F Cojocaru, B Ferrara, C Houppe

Eur J Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and physico-chemical investigation of thiolated dextran derivative: Design and application of a redox-responsive drug delivery system.
Cléa Chesneau, Andréa Pelletier, Pierre Dubot, Eric Leroy, Angélique Goffin

Int J Biol Macromol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy.
Raineri F, Larue L, Cojocaru C, Ferrara B, Houppe C

Eur J Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.
Anais Debesset, Caroline Pilon, Sylvain Meunier, Orianne Cuelenaere-Bonizec, Wilfrid Richer

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. 2022, 4265.
Matteo Ponzo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Matteo Ponzo, Anais Debesset, Mélissande Cossutta, Mounira Chalabi-Dchar, Claire Houppe

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymerization-Induced Self-Assembly (PISA) for in situ drug encapsulation or drug conjugation in cancer application.
Hien Phan, Mélissande Cossutta, Claire Houppe, Clémence Le Cœur, Sylvain Prevost

J Colloid Interface Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.
Fabio Raineri, Sandrine Bourgoin-Voillard, Mélissande Cossutta, Damien Habert, Matteo Ponzo

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option.
Benedetta Ferrara, Sabrina Belbekhouche, Damien Habert, Claire Houppe, Benoit Vallée

Nanotechnology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
Marie Darche, Mélissande Cossutta, Laure Caruana, Claire Houppe, Maud-Emmanuelle Gilles

FASEB J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.
Mélissande Cossutta, Marie Darche, Gilles Carpentier, Claire Houppe, Matteo Ponzo

Arterioscler Thromb Vasc Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.
Zoi Diamantopoulou, Maud-Emmanuelle Gilles, Maha Sader, Mélissande Cossutta, Benoit Vallée

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.
Maud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, Gilles Carpentier, Laure Caruana

Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis